HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Affinium Pharmaceuticals Ltd.

www.afnm.com

Latest From Affinium Pharmaceuticals Ltd.

Deals Shaping The Medical Industry, March 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January through February 2014.

BioPharmaceutical Medical Device

Deals Of The Week: UCSF Catalyzes R&D Tech-Transfer Deals With Private Sector

Through the Catalyst Awards program at its Clinical and Translational Science Institute, UCSF will give MedImmune access to a broad range of discovery and preclinical opportunities under a three-year agreement. Plus, Mallinckrodt buys Cadence, Debiopharm acquires Affinium’s antibiotics program, and more.

BioPharmaceutical Deals

Recent Financings of Private Companies (10/2011)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

Recent Financings of Private Companies (05/2007)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Integrative Proteomics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Affinium Pharmaceuticals Ltd.
  • Senior Management
  • Ed Mascioli, MD, CEO
    Owen Roberts, CFO
    Barry Hafkin, MD, CMO
  • Contact Info
  • Affinium Pharmaceuticals Ltd.
    Phone: (416) 645-6614
    7000 North Mopac Expwy.
    2nd. Fl
    Austin, TX 78731
    USA
UsernamePublicRestriction

Register